WASHINGTON - Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.

WASHINGTON - U.S. health regulators on Thursday authorized Merck’s COVID-19 pill, known as molnupiravir — the second medication approved for at-home use to battle the rapidly-spreading omicron variant ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

While Dr. Anthony Fauci of NIAID is already stressing that people should still get vaccinated to help reduce COVID-19 infections and end the pandemic, a new treatment has been developed that could be ...

CHICAGO, June 1 (Reuters) - Merck (MRK.N), opens new tab is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola treatment to ...